Alethios Launches New Research Data Collection Platform
The $100-per-month tool automates participant monitoring and lab coordination for decentralized clinical trials.
Updated on Oct. 28, 2026 in Remote Work
Live Poll
Do you trust the data collected from remote, decentralized health studies as much as clinical trials?
San Francisco-based firm Alethios has launched a suite of decentralized research tools designed to streamline clinical trial data collection. The platform integrates digital biomarkers and wearable data to automate the research process for teams running multi-week trials.
Why it matters
By automating participant follow-ups and data cleaning, the company aims to cut the time and overhead required for research studies. The platform is intended to help researchers manage complex trials without the need for traditional, onsite infrastructure.
The Alethios platform, which costs $100 per month, has supported five peer-reviewed papers and saw seven studies complete enrollment in under 24 hours over the past year. Whether these rapid enrollment speeds translate to broader research efficiency is still under observation.
The players
Alethios Inc.
A San Francisco-based technology company that develops decentralized tools for clinical research.
PLT Health Solutions
A partner organization that began using Alethios tools in June 2026 for decentralized clinical trials.
The details
The platform offers a no-code system that handles onboarding, device integration, and lab coordination for randomized, 12-week clinical trials. It pulls in data from wearables and participant-reported outcomes to manage multi-source research tasks. Researchers can now utilize these tools to automate workflows previously managed manually.
Timeline
June 2026: PLT Health Solutions partnered with Alethios.
October 28, 2026: Official details of the platform release were published.
Across the Bay
The transition to decentralized clinical trials follows the broader shift outlined by the FDA's guidance on remote research practices. Alethios extends this pattern by providing the specific automation tools necessary to make remote participant monitoring a standard practice.
Researchers and local tech teams can now subscribe to the platform for $100 per month to manage their data collection workflows. The tools are currently available for teams looking to automate trial onboarding and participant coordination.
The takeaway
This platform highlights a growing shift toward automated, at-home clinical data collection in research. Watch for whether decentralized study models become the default for short-term health trials in the coming year.
Further reading
For more on how local firms are building out digital infrastructure, visit the remote-work section.
Source note: This article includes information reported by NutraIngredients.
Live Poll
Do you trust the data collected from remote, decentralized health studies as much as clinical trials?
